Selected Financial Data
since 2019
Income Statement
Shockwave Medical Inc., selected items from income statement, long-term trends
US$ in thousands
| 12 months ended: | Revenue | Income (loss) from operations | Net income (loss) |
|---|---|---|---|
| Dec 31, 2023 | 730,230) | 159,093) | 147,278) |
| Dec 31, 2022 | 489,733) | 124,134) | 215,996) |
| Dec 31, 2021 | 237,146) | (871) | (9,136) |
| Dec 31, 2020 | 67,789) | (65,663) | (65,699) |
| Dec 31, 2019 | 42,927) | (51,839) | (51,109) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
- Revenue
- The revenue of the company has shown a substantial upward trend over the five-year period, starting at US$42.9 million in 2019 and reaching US$730.2 million in 2023. This indicates strong growth in the company's top line.
- Income (loss) from operations
- The income from operations has demonstrated a significant improvement from a loss of US$51.8 million in 2019 to a profit of US$159.1 million in 2023. The company has effectively turned around its operational performance, showing positive results.
- Net income (loss)
- The net income has fluctuated over the years but shows a notable increase from a loss of US$51.1 million in 2019 to a profit of US$147.3 million in 2023. Despite a dip in 2021, the company recovered strongly in terms of net profitability by the end of the period.
Balance Sheet: Assets
Shockwave Medical Inc., selected items from assets, long-term trends
US$ in thousands
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2023 | 1,225,260) | 1,566,563) |
| Dec 31, 2022 | 459,263) | 646,089) |
| Dec 31, 2021 | 285,902) | 345,682) |
| Dec 31, 2020 | 246,300) | 272,042) |
| Dec 31, 2019 | 216,697) | 231,938) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
- Current Assets:
- The company's current assets have shown a steady increase over the periods, more prominently accelerating from 2021 to 2023, indicating robust growth in short-term assets.
- Total Assets:
- Total assets have consistently grown year over year, with a significant surge observed between 2022 and 2023, indicating a substantial increase in the company's overall asset base.
Balance Sheet: Liabilities and Stockholders’ Equity
Shockwave Medical Inc., selected items from liabilities and stockholders’ equity, long-term trends
US$ in thousands
| Current liabilities | Total liabilities | Total debt | Stockholders’ equity | |
|---|---|---|---|---|
| Dec 31, 2023 | 104,205) | 897,886) | 731,863) | 668,677) |
| Dec 31, 2022 | 63,374) | 134,773) | 24,198) | 511,316) |
| Dec 31, 2021 | 51,628) | 103,852) | 17,130) | 241,830) |
| Dec 31, 2020 | 25,581) | 46,388) | 16,619) | 225,654) |
| Dec 31, 2019 | 24,008) | 39,285) | 13,819) | 192,653) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
- Current Liabilities
- The trend in current liabilities shows a steady increase over the years, more than doubling from 2019 to 2023. The significant growth may indicate increased short-term financial obligations.
- Total Liabilities
- Total liabilities have also seen a notable upward trajectory, almost reaching a tenfold increase from 2019 to 2023. This pattern suggests a substantial rise in overall obligations over time.
- Total Debt
- Total debt has shown a consistent rise annually, with a sharp escalation observed from 2022 to 2023. The latest figures indicate a substantial spike in debt levels, possibly due to increased borrowing.
- Stockholders’ Equity
- Stockholders' equity has steadily increased throughout the period, showing a more moderate growth compared to liabilities. The equity amount shows a continuous positive trend, indicating a healthy shareholder position.
Cash Flow Statement
Shockwave Medical Inc., selected items from cash flow statement, long-term trends
US$ in thousands
| 12 months ended: | Net cash provided by (used in) operating activities | Net cash (used in) provided by investing activities | Net cash provided by (used in) financing activities |
|---|---|---|---|
| Dec 31, 2023 | 196,053) | (625,727) | 600,401) |
| Dec 31, 2022 | 117,732) | (62,150) | 12,999) |
| Dec 31, 2021 | 15,036) | 26,416) | (2,451) |
| Dec 31, 2020 | (71,184) | (107,473) | 90,035) |
| Dec 31, 2019 | (48,107) | (59,543) | 208,052) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
- Net cash from operating activities:
- The company experienced a positive trend in net cash provided by operating activities over the periods, with a notable increase from 2019 to 2023. The values improved steadily, reaching a significant high of $196,053k in 2023.
- Net cash from investing activities:
- The trend in net cash used in investing activities fluctuated over the years, with negative values in 2019, 2020, and 2022, indicating substantial cash outflows. However, there was a substantial increase to positive $26,416k in 2021 before reverting to a large negative value in 2023.
- Net cash from financing activities:
- The data shows a mix of positive and negative values for net cash provided by financing activities. While the values were mostly positive, there were negative figures in 2021 and 2023. The highest positive value recorded was $600,401k in 2023.
Per Share Data
Shockwave Medical Inc., selected data per share, long-term trends
US$
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Dec 31, 2023 | 4.01 | 3.85 | 0.00 |
| Dec 31, 2022 | 6.02 | 5.70 | 0.00 |
| Dec 31, 2021 | -0.26 | -0.26 | 0.00 |
| Dec 31, 2020 | -1.99 | -1.99 | 0.00 |
| Dec 31, 2019 | -2.14 | -2.14 | 0.00 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.
- Basic Earnings per Share:
- The company's basic earnings per share improved significantly over the periods analyzed, starting at -2.14 in 2019 and steadily increasing to reach 4.01 in 2023.
- Diluted Earnings per Share:
- Similar to basic earnings per share, diluted earnings per share showed a positive trend, rising from -2.14 in 2019 to 3.85 in 2023.
- Dividend per Share:
- Unfortunately, there is no data available for the dividend per share. Further information is needed to assess the company's dividend policy.